Pharming PHAR
NASDAQ PHAR
$13.40 +0.38 (+2.92%)
As of: Nov 11, 2026 · 3:17 PM EST

Pharming (PHAR) Other Accumulated Expenses (2019 - 2024)

Updated

Pharming's Other Accumulated Expenses was -$644,000 in Q4 2023, compared with -$157,000 a year earlier.

Analysis

Pharming (PHAR) Other Accumulated Expenses (2019 - 2024) Analysis & Trends

From Q4 2019 onward, Pharming has reported Other Accumulated Expenses for 13 quarters.

  • In earlier years, Other Accumulated Expenses was -$157,000 in FY2022, -$625,000 in FY2021, -$850,000 in FY2020 and $8.93 million in FY2019.
  • Quarterly Other Accumulated Expenses has moved between -$12.61 million (Q2 2022) and $14.67 million (Q2 2021) over five years.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Pharming 927.62 Mn 229.29 Mn 102.20
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 5.92 Mn
Dec 31, 2023 3.48 Mn
Sep 30, 2023 -10.92 Mn
Jun 30, 2023 -6.04 Mn
Dec 31, 2022 3.55 Mn
Sep 30, 2022 -24,145.00
Jun 30, 2022 -12.61 Mn
Mar 31, 2022 -910,000.00
Dec 31, 2021 2,171.01
Sep 30, 2021 9.86 Mn
Jun 30, 2021 14.67 Mn
Mar 31, 2021 11,358.00
Dec 31, 2020 5.34 Mn
Dec 31, 2019 4.17 Mn
API Access

Pharming Other Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=PHAR&period=max&api_key=YOUR_API_KEY